Clinical trials: Vestibulodynia
Vulvodynia
A Phase 2 Study to Evaluate the Efficacy and Safety of Pudafensine in Vulvodynia (Provoked Vestibulodynia)
The study (IP2015CS05) is a randomised, double-blind, placebo-controlled, 4-way cross-over trial studying the efficacy and safety of single dose administration of pudafensine in vulvodynia (provoked vestibulodynia) patients.
- Trial name
- NCT07391241
- Testing
- Pudafensine
- Where
- United Kingdom
- Volunteers
- 24 people
- Sponsor
- Initiator Pharma